Babies affected by a severe muscle wasting disease, such as Jesy Nelson’s twins, are being overlooked by the government, according to campaigners. Jesy, a former member of the popular group Little Mix, along with other parents of infants born with spinal muscular atrophy (SMA), recently participated in a parliamentary debate urging for universal testing of newborns for this condition. Early NHS treatments are highly effective in curing SMA if administered at birth to prevent irreversible nerve damage in the initial weeks of life.

During a recent government update, Health Minister Sharon Hodges informed MPs and advocates that an ongoing NHS pilot program is hesitant to expand testing to more than 160,000 newborns annually, citing the need to ensure that screening benefits outweigh potential risks. Campaigners are concerned that the government’s stance has shifted following the resignation of the previous health secretary, who had pledged to explore extending screening to all newborns.

SMA UK, a charity supporting individuals with SMA, expressed disappointment with the government’s response, stressing the urgency of timely action. The organization highlighted that since the commitment to consider nationwide testing was made, several babies have likely been born with SMA without receiving timely diagnosis and treatment, leading to significant health challenges.

Giles Lomax, CEO of SMA UK, emphasized the critical need for expanded screening, pointing out the continued delay in implementing comprehensive testing despite previous promises. The delay in addressing this issue has raised concerns within the SMA community and advocates for rare disease awareness.

Former pop star Jesy Nelson has teamed up with the Mirror to advocate for comprehensive SMA screening for all newborns. She shared her personal experience of delayed diagnosis in her twins, underscoring the importance of early intervention to prevent long-term health complications.

In response to the growing pressure, the Department of Health and Social Care announced plans for a large-scale trial across the NHS to screen hundreds of thousands of babies for SMA starting earlier than initially scheduled. This initiative aims to gather crucial data to support the establishment of a nationwide screening program and ensure better outcomes for children affected by SMA.